Blog

AcuraStem Welcomes Dr. Ananya Sengupta as Associate Director of Program Management
Jun 24, 2024, 11:01 AM
AcuraStem, a patient-based biotechnology company pioneering the development of treatments for neurodegenerative diseases, today announced the appointment of Dr. Ananya Sengupta as Associate Director of Program Management
Dr. Wen-Hsuan Chang to Speak at 5th International Oligonucleotides and Peptides Conference
Jun 21, 2024, 3:35 PM
AcuraStem’s Associate Vice President, Discovery and Early Development, Dr. Wen-Hsuan (Wen) Chang, will present at the 5th International Oligonucleotides and Peptides Conference (IOPC) on June 26, 2024, in Milan
AcuraStem Names Dr. Wen-Hsuan Chang Associate Vice President, Discovery and Early Development
Jun 18, 2024, 6:41 PM
AcuraStem, a patient-based biotechnology company pioneering the development of treatments for neurodegenerative diseases, today announced it has named Dr. Wen-Hsuan Chang as Associate Vice President of Discovery and Early Development
AcuraStem Sponsors IgNight ALS, Celebrating Steve Gleason's Legacy and Inspiring Hope in the ALS Community
Jun 18, 2024, 6:32 PM
AcuraStem proudly sponsored the recent IgNight ALS event in Washington, D.C., a poignant evening dedicated to celebrating Steve Gleason and his profound contributions to the ALS community
AcuraStem Welcomes New Team Member and Promotes Key Leaders to Propel Neurodegenerative Disease Research
Jun 3, 2024, 4:19 PM
AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced the expansion of its team with three new team members, bringing a fresh influx of expertise to its pioneering platform.
Topics
Archives